Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
Hong Kong-based biomed pioneer is at the forefront in a global race to develop cell and gene treatments for cancers and other ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
Twist Bioscience Corporation , a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025. Visit the Events ...
Researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing ...
Low expression of BAZ2B may promote breast cancer progression by reshaping tumour metabolism. Read on to learn more.
In the twentieth century, identity was something one received and cultivated. Today it is something one produces and displays ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
Bionova Scientific LLC, an Asahi Kasei company and a bespoke contract development and manufacturing organization (CDMO), announced a strategic manufacturing alliance with Syenex, a genetic medicines ...
An Abuja-based medical expert, Dr Maryam Ahmed Almustapha, has raised an alarm over the potentially devastating effects of ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback